NCT06124638 - Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use | Biotech Hunter

Enrollment

624

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions

COVID-19Influenza AInfluenza Type B

Interventions

DIAGNOSTIC_TEST

Panbio™ COVID-19/Flu A&B Panel

The Panbio™ COVID-19/Flu A\&B Rapid Panel Self-Test device is a visual lateral flow assay, for rapid immunochromatographic qualitative detection of COVID-19 antigen, Influenza A antigen and Influenza B antigen in self-collected mid-turbinate nasal swabs. The test is designed to be used by lay users.

Trial Locations (2)

11219

Maimonides Medical Center, Brooklyn

35124

Cahaba Research Inc, Pelham

All Listed Sponsors

lead

Abbott Rapid Dx

INDUSTRY